Geneos Therapeutics Patents – Insights & Stats (Updated 2023)

Geneos Therapeutics has a total of 8 patents globally. Out of these 8 patents, more than 87% patents are active. The United States of America seems to be the main focused R&D center and also the origin country of Geneos Therapeutics.

Geneos Therapeutics was founded in the year 2016. Geneos Therapeutics is a biotechnology company. The company creates cancer immunotherapies that target neoantigens.

Do read about some of the most popular patents of Geneos Therapeutics which have been covered by us in this article and also you can find Geneos Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Geneos Therapeutics patent portfolio.

How many patents does Geneos Therapeutics have?

Geneos Therapeutics has a total of 8 patents globally. These patents belong to 1 unique patent family. Out of 8 patents, 7 patents are active.

How Many Patents did Geneos Therapeutics File Every Year?

Geneos Therapeutics Patents Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantGeneos Therapeutics Applications FiledGeneos Therapeutics Patents Granted

How many Geneos Therapeutics patents are Alive/Dead?

Worldwide Patents

Geneos Therapeutics Patents Portfolio

How Many Patents did Geneos Therapeutics File in Different Countries?

Geneos Therapeutics Worldwide Patents

Countries in which Geneos Therapeutics Filed Patents

Europe (EPO)1
Hong Kong (S.A.R.)1
United States Of America1

Where are Research Centers of Geneos Therapeutics Patents Located?

The Research Centre for all the Geneos Therapeutics patents is the United States of America.

List of Geneos Therapeutics Patents

Geneos Therapeutics PatentsTitle
US20210361755A1Tumor-Specific Neoantigens And Methods Of Using The Same
EP3801597A4Tumor-Specific Neoantigens And Methods Of Using The Same
CA3100974A1Tumor-Specific Neoantigens And Methods Of Using The Same
JP2021525549A5Tumor-Specific Neoantigens And Methods Of Use Thereof
HK40048130ATumor-Specific Neoantigens And Methods Of Using The Same
IN202017048827ATumor-Specific Neoantigens And Methods Of Using The Same
MX2020012649ATumor-Specific Neoantigens And Methods Of Using The Same.
WO2019227106A9Tumor-Specific Neoantigens And Methods Of Using The Same

What are Geneos Therapeutics key innovation segments?

What Technologies are Covered by Geneos Therapeutics?

The chart below distributes patents filed by Geneos Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Geneos Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Geneos Therapeutics search focus changed over the years?


Interested in knowing about the areas of innovation that are being protected by Geneos Therapeutics?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.